Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating complement-associated disorders with anti-C5a antibodies

Methods of treating complement-associated disorders with anti-C5a antibodies

US Patent 9469690 · Granted Oct 18, 2016

Estimated economic value: $218,246,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Catalyst and catalytic oxidation-deoxidation method for unsaturated hydrocarbon-2025
Monovalent anti-properdin antibodies and antibody fragments2025
Monovalent anti-properdin antibodies and antibody fragments2025
Subcutaneous dosage and administration of anti-C5 antibodies for treatment of pa2025
Polypeptides that bind complement component C5 or serum albumin and fusion prote2025
Polypeptides that bind complement component C5 or serum albumin and fusion prote2025
Tandem solar cell2024
Stacked solar cell2024
Methods and compositions for treating complement-associated disorders2023
Humanized anti-CD200 antibodies and uses thereof2023
Polypeptides that bind complement component C5 or serum albumin and fusion prote2022
Polypeptides that bind complement component C5 or serum albumin and fusion prote2022